In addition, a growing body of evidence has demonstrated that SERPINE1 expression is associated with poor prognosis in patients with breast (Look et al., 2002), ovarian (Chambers et al., 1998), colon (Sakakibara et al., 2005) and gastric (Sakakibara et al., 2006) cancers. Here, SERPINE1 is linked to cancer.